Immunomedics Inc (IMMU)

3.26
0.01 0.31
NASDAQ : Health Care
Prev Close 3.27
Open 3.24
Day Low/High 3.20 / 3.33
52 Wk Low/High 1.50 / 5.44
Volume 604.77K
Avg Volume 1.09M
Exchange NASDAQ
Shares Outstanding 95.87M
Market Cap 316.36M
EPS -0.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Curiouser and Curiouser

A nice rally, but what's the deal with the banks and tech?

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Immunomedics, Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of August 8, 2016

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Immunomedics, Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of August 8, 2016

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Immunomedics, Inc.

SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of Commencement Of A Class Action Involving Immunomedics, Inc. And A Lead Plaintiff Deadline Of August 8, 2016 - IMMU

SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of Commencement Of A Class Action Involving Immunomedics, Inc. And A Lead Plaintiff Deadline Of August 8, 2016 - IMMU

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased Immunomedics, Inc.

September 16th Options Now Available For Immunomedics (IMMU)

September 16th Options Now Available For Immunomedics (IMMU)

Investors in Immunomedics, Inc. saw new options become available today, for the September 16th expiration.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Immunomedics, Inc. Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of August 8, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Immunomedics, Inc. Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of August 8, 2016

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Immunomedics, Inc.

SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of Commencement Of A Class Action Involving Immunomedics, Inc. And A Lead Plaintiff Deadline Of August 8, 2016

SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of Commencement Of A Class Action Involving Immunomedics, Inc. And A Lead Plaintiff Deadline Of August 8, 2016

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased Immunomedics, Inc.

UPCOMING DEADLINE ALERT - Immunomedics, Inc. - Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 To Contact The Firm

UPCOMING DEADLINE ALERT - Immunomedics, Inc. - Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 To Contact The Firm

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of...

SHAREHOLDER NOTICE: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Immunomedics Inc. And Reminds Investors With Losses To Contact The Firm

SHAREHOLDER NOTICE: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Immunomedics Inc. And Reminds Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces that a class action lawsuit has been filed against Immunomedics Inc.

Immunomedics Announces New U.S. Patent For Sacituzumab Govitecan (Immu-132) Antibody-Drug Conjugate (ADC)

Immunomedics Announces New U.S. Patent For Sacituzumab Govitecan (Immu-132) Antibody-Drug Conjugate (ADC)

Clinical Development Plan in Triple-Negative Breast Cancer Updated

IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against Immunomedics Inc. And Reminds Investors With Losses To Contact The Firm

IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against Immunomedics Inc. And Reminds Investors With Losses To Contact The Firm

Lundin Law PC announces a class action lawsuit has been filed against Immunomedics Inc.

SHAREHOLDER ALERT: Rosen Law Firm Reminds Immunomedics, Inc. Investors Of Important Deadline In Class Action - IMMU

SHAREHOLDER ALERT: Rosen Law Firm Reminds Immunomedics, Inc. Investors Of Important Deadline In Class Action - IMMU

Rosen Law Firm, a global investor rights law firm, reminds purchasers of Immunomedics, Inc.

First Week of IMMU February 2017 Options Trading

First Week of IMMU February 2017 Options Trading

Investors in Immunomedics, Inc. saw new options begin trading this week, for the February 2017 expiration.

IMMUNOMEDICS, INC. INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

IMMUNOMEDICS, INC. INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of...

IMMUNOMEDICS, INC. INVESTOR ALERT: Hagens Berman Alerts Immunomedics, Inc. Investors Of Investigation Into Company's ASCO Rule Violation

IMMUNOMEDICS, INC. INVESTOR ALERT: Hagens Berman Alerts Immunomedics, Inc. Investors Of Investigation Into Company's ASCO Rule Violation

The following statement is being issued by Hagens Berman Sobol Shapiro LLP: Hagens Berman is investigating Immunomedics, Inc.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Immunomedics, Inc. - IMMU

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Immunomedics, Inc. - IMMU

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Immunomedics, Inc.

Today's Dead Cat Bounce Stock: Immunomedics (IMMU)

Today's Dead Cat Bounce Stock: Immunomedics (IMMU)

Trade-Ideas LLC identified Immunomedics (IMMU) as a "dead cat bounce" (down big yesterday but up big today) candidate